Zydus Cadila Seeks DCGI Nod To Undertake Clinical Trials for Monoclonal Antibodies Cocktail That Can Neutralise COVID-19 Infection

Pharmaceutical company Zydus Cadila on Thursday sought the approval of the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection. 

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)